Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00112_DB01268> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00112_DB01268 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00112_DB01268 label "DDI between Bevacizumab and Sunitinib - Sunitinib may enhance the adverse/toxic effect of bevacizumab. Specifically, the risk for a specific form of anemia, microangiopathic hemolytic anemia (MAHA), may be increased. Bevacizumab may enhance the hypertensive effect of sunitinib. This combination is contraindicated. [drugbank_resource:DB00112_DB01268]" assertion.
- drugbank_resource:DB00112_DB01268 identifier "drugbank_resource:DB00112_DB01268" assertion.
- drugbank_resource:DB00112_DB01268 title "DDI between Bevacizumab and Sunitinib - Sunitinib may enhance the adverse/toxic effect of bevacizumab. Specifically, the risk for a specific form of anemia, microangiopathic hemolytic anemia (MAHA), may be increased. Bevacizumab may enhance the hypertensive effect of sunitinib. This combination is contraindicated." assertion.